Advertisement
U.S. Markets closed
S&P Futures
5,895.75 -0.50 (-0.01%) Dow Futures
43,155.00 -22.00 (-0.05%) Nasdaq Futures
20,513.25 -6.25 (-0.03%) Russell 2000 Futures
2,252.60 -2.90 (-0.13%) Crude Oil
70.54 -0.02 (-0.03%) Gold
2,735.60 -3.30 (-0.12%)
Century Therapeutics, Inc. (IPSC)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 1.6000 |
| Open | 1.5900 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.5200 - 1.6000 |
| 52 Week Range | 1.2800 - 5.5100 |
| Volume | |
| Avg. Volume | 325,325 |
| Market Cap | 130.463M |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates
Century Therapeutics (IPSC) delivered earnings and revenue surprises of 24% and 40.18%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
After losing 17% in the past year, Century Therapeutics, Inc. (NASDAQ:IPSC) institutional owners must be relieved by the recent gain
Key Insights Institutions' substantial holdings in Century Therapeutics implies that they have significant influence...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.